Skip to main content
Top
Published in: Comparative Clinical Pathology 4/2019

01-08-2019 | Albendazole | Original Article

Ultrastructural changes on fertile and infertile hydatid cysts induced by conventional and solid lipid nanoparticles of albendazole and albendazole sulfoxide

Authors: Abdollah Rafiei, Shahrzad Soltani, Zahra Ramezani, Mohammad Reza Abbaspour, Ali Jelowdar, Mehdi Sagha Kahvaz

Published in: Comparative Clinical Pathology | Issue 4/2019

Login to get access

Abstract

Cystic echinococcosis (CE), a serious public health problem worldwide, is caused by the larval stage of Echinococcus granulosus (E. granulosus). Despite recent progress in the CE medical treatment, this subject still remains as a priority of research. Albendazole (ABZ) is a drug of choice for the treatment of hydatidosis. Its use as an antiparasitic agent with the most efficacy is limited by the lack of water solubility. Therefore, the aim of the present study was to compare in vitro efficacy of free and solid lipid nanoparticles (SLNs) of ABZ and albendazole sulfoxide (ABZSO) against fertile and infertile hydatid cysts in terms of ultrastructural changes. ABZ-SLN and ABZSO-SLN were produced by micro emulsification and high shear homogenization technique and the physicochemical characterization of the product was evaluated. Then, the structural alterations occurring due to treatment with free and SLN formulations against fertile and infertile sheep liver hydatid cysts were assessed by optical and transmission electron microscopy (TEM) examinations. Untreated control groups revealed the typical appearance of hydatid cysts; in contrast, all treated cysts exhibited degenerative alterations with various rates. Loading ABZ and ABZSO into SLN leads to greater structural changes. In both prepared formulations, better efficacy was observed in fertile and small cysts.
Literature
go back to reference Dolatabadi JEN, Jamali AA, Hasanzadeh M, Omidi Y (2011) Quercetin delivery into cancer cells with single walled carbon nanotubes. Int J Biosci Biochem Bioinforma 1(1):21–25 Dolatabadi JEN, Jamali AA, Hasanzadeh M, Omidi Y (2011) Quercetin delivery into cancer cells with single walled carbon nanotubes. Int J Biosci Biochem Bioinforma 1(1):21–25
go back to reference Kelidari HR, Akbari J, Saeedi M (2013) Application and characterization of solid lipid nanoparticles and nanostructured lipid carriers as drug delivery systems. J Mazandaran Uni Med Sci 23(98):387–403 Kelidari HR, Akbari J, Saeedi M (2013) Application and characterization of solid lipid nanoparticles and nanostructured lipid carriers as drug delivery systems. J Mazandaran Uni Med Sci 23(98):387–403
go back to reference Perez-Serrano J, Denegri G, Casado N, Rodriguez-Caabeiro F (1997) In vivo effect of oral albendazole and albendazole sulphoxide on development of secondary echinococcosis in mice. Int J Parasitol 27(11):1341–1345CrossRefPubMed Perez-Serrano J, Denegri G, Casado N, Rodriguez-Caabeiro F (1997) In vivo effect of oral albendazole and albendazole sulphoxide on development of secondary echinococcosis in mice. Int J Parasitol 27(11):1341–1345CrossRefPubMed
go back to reference Skuhala T, Trkulja V, Runje M, Vukelic D, Desnica B (2014) Albendazolesulphoxide concentrations in plasma and hydatid cyst and prediction of parasitological and clinical outcomes in patients with liver hydatidosis caused by Echinococcus granulosus. Croat Med J 55(2):146–155CrossRefPubMedPubMedCentral Skuhala T, Trkulja V, Runje M, Vukelic D, Desnica B (2014) Albendazolesulphoxide concentrations in plasma and hydatid cyst and prediction of parasitological and clinical outcomes in patients with liver hydatidosis caused by Echinococcus granulosus. Croat Med J 55(2):146–155CrossRefPubMedPubMedCentral
go back to reference de Souza MC, Marchetti JM (2012) Development of albendazole sulfoxide-loaded Eudragit microparticles: a potential strategy to improve the drug bioavailability. Adv Powder Technol 23(6):801–807CrossRef de Souza MC, Marchetti JM (2012) Development of albendazole sulfoxide-loaded Eudragit microparticles: a potential strategy to improve the drug bioavailability. Adv Powder Technol 23(6):801–807CrossRef
go back to reference Torgerson PR, Devleesschauwer B, Praet N, Speybroeck N, Willingham AL, Kasuga F, Rokni MB, Zhou XN, Fèvre EM, Sripa B, Gargouri N, Fürst T, Budke CM, Carabin H, Kirk MD, Angulo FJ, Havelaar A, de Silva N (2015) World Health Organization estimates of the global and regional disease burden of 11 foodborne parasitic diseases, 2010: a data synthesis. PLoS Med 12(12):e1001920. https://doi.org/10.1371/journal.pmed.1001920 CrossRefPubMedPubMedCentral Torgerson PR, Devleesschauwer B, Praet N, Speybroeck N, Willingham AL, Kasuga F, Rokni MB, Zhou XN, Fèvre EM, Sripa B, Gargouri N, Fürst T, Budke CM, Carabin H, Kirk MD, Angulo FJ, Havelaar A, de Silva N (2015) World Health Organization estimates of the global and regional disease burden of 11 foodborne parasitic diseases, 2010: a data synthesis. PLoS Med 12(12):e1001920. https://​doi.​org/​10.​1371/​journal.​pmed.​1001920 CrossRefPubMedPubMedCentral
go back to reference Wu XW, Chen XL, Zhang SJ, Zhang X, Sun H, Peng XY (2011) Pericyst may be a new pharmacological and therapeutic target for hydatid disease. Chin Med J 124(18):2857–2862PubMed Wu XW, Chen XL, Zhang SJ, Zhang X, Sun H, Peng XY (2011) Pericyst may be a new pharmacological and therapeutic target for hydatid disease. Chin Med J 124(18):2857–2862PubMed
Metadata
Title
Ultrastructural changes on fertile and infertile hydatid cysts induced by conventional and solid lipid nanoparticles of albendazole and albendazole sulfoxide
Authors
Abdollah Rafiei
Shahrzad Soltani
Zahra Ramezani
Mohammad Reza Abbaspour
Ali Jelowdar
Mehdi Sagha Kahvaz
Publication date
01-08-2019
Publisher
Springer London
Keyword
Albendazole
Published in
Comparative Clinical Pathology / Issue 4/2019
Print ISSN: 1618-5641
Electronic ISSN: 1618-565X
DOI
https://doi.org/10.1007/s00580-019-02925-y

Other articles of this Issue 4/2019

Comparative Clinical Pathology 4/2019 Go to the issue